title: Anterior pituitary function in Cushing's syndrome: study of 36 patients.
abstract: We studied the anterior pituitary function in 36 patients (25 females and 11 males, mean age: 35 years) with untreated Cushing's syndrome by simultaneous triple stimulus with insulin, TRH and LHRH. Thirty-one patients (86%) had Cushing's disease and five (14%) had an adrenal adenoma. We observed a lack of response of GH to hypoglycemia in 88%, TSH to TRH in 91%, LH to LHRH in 30%, FSH to LHRH in 12% and PRL to TRH in 6% of the patients. Low-to-normal total thyroxine (T4) values were obtained in 37%, with low triiodothyronine levels in 87%. The free-T4 index was normal in all patients. Total testosterone was low in only one adult man, while estradiol and progesterone were low in 45% and 15% of premenopausal women, respectively. We observed no differences in either axis among patients with Cushing's syndrome of different etiologies. Nor was there any statistical difference between the frequency of alteration of each axis and the levels of urinary free cortisol or the duration of the disease. We conclude that hypercortisolism is responsible for the abnormalities in anterior pituitary function in Cushing's syndrome.
authors.affiliation: Service of Endocrinology, Clinica Puerta de Hierro Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Cuerda
authors.forename: J
authors.initials: J
authors.lastname: Estrada
authors.forename: M
authors.initials: M
authors.lastname: Marazuela
authors.forename: A
authors.initials: A
authors.lastname: Vicente
authors.forename: B
authors.initials: B
authors.lastname: Astigarraga
authors.forename: I
authors.initials: I
authors.lastname: Bernabeu
authors.forename: S
authors.initials: S
authors.lastname: Diez
authors.forename: L
authors.initials: L
authors.lastname: Salto
mesh_terms: D000236:Adenoma / Q000378:metabolism; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000378:metabolism; D000328:Adult; D000368:Aged; D002648:Child; D003480:Cushing Syndrome / Q000097:blood*; D004338:Drug Combinations; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007003:Hypoglycemia / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D010907:Pituitary Hormones / Q000097:blood*; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000097:blood; D013739:Testosterone / Q000097:blood; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D004338:Drug Combinations; D007328:Insulin; D010907:Pituitary Hormones; D014284:Triiodothyronine; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D013974:Thyroxine